Article

Effectiveness of mepolizumab in a real-life cohort of patients with severe refractory eosinophilic asthma and multiple comorbidities

2020-06-02

Abstract excerpt

<h4>BACKGROUND</h4> Patients with severe asthma often suffer from comorbidities whose impact on the course of biological therapy has not been elucidated yet. <h4>OBJECTIVE</h4> To evaluate real-life effectiveness and the presence/absence of predictors of treatment response in patients with one or more comorbidities who received mepolizumab (MEPO) for the treatment of severe eosinophilic asthma (EA). <h4>METHODS</h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c10a5976-8bc0-5470-a1cf-debb3c574799
DOI: 10.1101/2020.05.26.20112052

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Effectiveness of mepolizumab in a real-life cohort of patients with severe refractory eosinophilic asthma and multiple comorbiditiesDOI 10.1101/2020.05.26.20112052Read

Mepolizumab real-world effectiveness in severe asthma with an eosinophilic phenotype and overlapping severe allergic asthma.Semantic proximity Read

Comorbidities Modify the Phenotype but Not the Treatment Effectiveness to Mepolizumab in Severe Eosinophilic Asthma.Semantic proximity Read

The efficacy of omalizumab treatment in patients with non-atopic severe asthmaSemantic proximity Read

Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotypeSemantic proximity Read

Biologics in severe asthma: the overlap endotype - opportunities and challenges.Semantic proximity Read

Influence of effective omalizumab treatment on eosinophils in allergic asthma with comorbiditiesSemantic proximity Read

Clinical characteristics and biological treatment responses of patients with late-onset asthma phenotype.Semantic proximity Read

Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic PhenotypeSemantic proximity Read

Clinical Recommendations for the Management of Biological Treatments in Severe Asthma Patients: A Consensus Statement.Semantic proximity Read

Phenotypes and Clinical Outcomes of Omalizumab and Mepolizumab treated Difficult Asthma patientsSemantic proximity Read

Severe asthma phenotypes in patients controlled with omalizumab: A real-world study.Semantic proximity Read

Mepolizumab for eosinophilic COPD with frequent exacerbations: single-centre real-world experience in a phenotype-directed approach.Semantic proximity Read